XPhyto Therapeutics CEO Hugh Rogers joined Steve Darling from Proactive to share details the company and their partner 3a-diagnostics have successfully registered their first biosensor test in oral inflammation with the German authorities.
Rogers telling Proactive this will be an at-home self-check that can be performed without the need for specific medical knowledge or training, analytical equipment or even a power supply.
Roger saying, this biosensor, placed on the tongue, the thin film dissolves and, after 5 minutes, the biosensor releases a bitter taste in case of oral inflammation.